Registration Statement · S-1
Propanc Biopharma, Inc.
PPCBNASDAQEQUITYCurrent
Registration Statement
Company context
We are a development-stage healthcare company that is currently focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancer. Utilizing our scientific and oncology consultants, we have developed a rational, composite formulation of anti-cancer compounds, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Our lead product candidate, PRP, is a variation upon our novel formulation and involves pro-enzymes, the inactive precursors of enzymes.
Current securities
As-filed source
As filedOpen full document ↗